Special Issue "Recent Advances in Skin Drug Delivery"
Deadline for manuscript submissions: 30 November 2023 | Viewed by 7836
Interests: transdermal drug delivery; topical application; thermotropic liquid crystals; prodrugs for transdermal delivery
Interests: biological barriers; drug delivery systems; nanoparticles; liposomes
Skin drug delivery is associated with a convenient noninvasive, targeted, and on-demand route of administration for the treatment of various diseases. Although skin constitutes an ideal platform to achieve both local and systemic effects of drug substances, skin drug delivery remains challenging due to the protective properties of the skin barrier, which consequently often limits the penetration and permeation of drug molecules.
A variety of methods have been developed to investigate and eventually improve skin penetration and permeation, including chemical enhancers, novel formulations and physical approaches. Improved penetration-enhancement strategies led to a resurgence of interest in transdermal drug delivery to the systemic circulation. Given that only a small number of transdermal formulations are commercially available, further advancement of skin drug delivery requires the development of novel delivery systems and approaches that are suitable for compounds distinguished by physicochemical properties and molecular sizes.
Undoubtedly, any targeted and active skin drug delivery vision promoting increased drug bioavailability should comprise an encouraging approach for the safe and efficient transfer of therapeutic molecules. On the other hand, no less important is the delivery of topical drugs directly to various skin structures with minimal penetration into the systemic circulation.
This Special Issue aims to provide readers with the recent advancements in drug delivery across the skin, for both topical and systemic applications. We welcome the submission of original research and review articles focused on the above-described subjects.
Dr. Iryna Kravchenko
Prof. Dr. Claus-Michael Lehr
Dr. Mariia Nesterkina
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- skin drug delivery
- permeation and penetration
- physical and chemical enhancers
- nanoparticles and nanocarriers
- 3D printed forms
- liquid crystals
- sustained/controlled release
- therapy ultrasound
- topical application
- skin segmentation